Related Experiment Video
Updated: Jul 15, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Post-treatment Radiographic Severity and Mortality in Mycobacterium avium Complex Pulmonary Disease
Joong-Yub Kim1,2, Seowoo Lee3, Hyungin Park3
1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, and.
Abstract:
Rationale: Imaging studies are widely performed when treating Mycobacterium avium complex pulmonary disease (MAC-PD); however, the clinical significance of post-treatment radiographic change is unknown. Objectives: To determine whether a deep neural network trained with pulmonary tuberculosis could adequately score the radiographic severity of MAC-PD and then to examine relationships between post-treatment radiographic severity and its change from baseline and long-term prognosis. Methods: We retrospectively collected chest radiographs of adult patients with MAC-PD treated for ⩾6 months at baseline and at 3, 6, 9, and 12 months of treatment. We correlated the radiographic severity score generated by a deep neural network with visual and clinical severity as determined by radiologists and mycobacterial culture status, respectively. The associations between the score, improvement from baseline, and mortality were analyzed using Cox proportional hazards regression. Results: In total, 342 and 120 patients were included in the derivation and validation cohorts, respectively. The network's severity score correlated with radiologists' grading (Spearman coefficient, 0.40) and mycobacterial culture results (odds ratio, 1.02; 95% confidence interval [CI], 1.0-1.05). A significant decreasing trend in the severity score was observed over time (P < 0.001). A higher score at 12 months of treatment was independently associated with higher mortality (adjusted hazard ratio, 1.07; 95% CI, 1.03-1.10). Improvements in radiographic scores from baseline were associated with reduced mortality, regardless of culture conversion (adjusted hazard ratio, 0.42; 95% CI, 0.22-0.80). These findings were replicated in the validation cohort. Conclusions: Post-treatment radiographic severity and improvement from baseline in patients with MAC-PD were associated with long-term survival.
Insights
Radiographic severity in Mycobacterium avium complex pulmonary disease (MAC-PD) post-treatment predicts survival. Improved imaging scores correlate with reduced mortality, regardless of culture conversion, offering prognostic insights.
Area of Science:
- Pulmonary Medicine
- Radiology
- Artificial Intelligence in Medicine
Background:
- Imaging is crucial for Mycobacterium avium complex pulmonary disease (MAC-PD) management.
- The prognostic value of radiographic changes after MAC-PD treatment remains unclear.
Purpose of the Study:
- To assess a deep neural network's ability to score MAC-PD radiographic severity.
- To investigate the association between post-treatment radiographic severity, changes from baseline, and long-term patient prognosis.
Main Methods:
- Retrospective analysis of chest radiographs from MAC-PD patients treated for at least six months.
- Correlation of deep neural network severity scores with radiologist assessments and mycobacterial culture status.
- Cox proportional hazards regression to analyze associations between radiographic scores, improvement, and mortality.
Main Results:
- Deep neural network scores correlated with radiologist grading and mycobacterial culture results.
- A significant decrease in radiographic severity scores was observed over treatment duration.
- Higher post-treatment severity scores and lower improvement from baseline were independently associated with increased mortality.
Conclusions:
- Post-treatment radiographic severity and improvement in MAC-PD patients are linked to long-term survival.
- Deep neural networks can effectively assess radiographic severity in MAC-PD.
- Radiographic changes provide valuable prognostic information for MAC-PD.
Related Concept Videos
Pneumonia III: Complications and Assessment
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumothorax-II
Clinical Manifestations:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

